<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03486288</url>
  </required_header>
  <id_info>
    <org_study_id>BB 192/17</org_study_id>
    <nct_id>NCT03486288</nct_id>
  </id_info>
  <brief_title>Cognitive Impairment Following Elective Spine Surgery</brief_title>
  <acronym>CONFESS</acronym>
  <official_title>Kognitive Störungen Nach Elektiver Wirbelsäulenchirurgie Bei Älteren</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medicine Greifswald</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medicine Greifswald</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Older people are a rapidly growing proportion of the world's population and their number is
      expected to increase twofold by 2050. When these people become patients that require surgery,
      they are at particular high risk for postoperative delirium (POD), which is associated with
      longer hospital stays, higher costs, risk for delayed complications and cognitive dysfunction
      (POCD). Having suffered an episode of delirium is furthermore a predictor of long-term care
      dependency. Despite these risks, an increasing number of elderly undergo major elective
      surgery. This is reflected by the frequency of elective spinal surgery, in general, and
      instrumented fusions, in particular, which has markedly increased over the past few decades.

      It is yet insufficiently understood, which, particularly modifiable, factors contribute to
      the development of POD and POCD following these major but plannable surgeries. A better
      understanding of risk factors would facilitate informed patient decisions and surgical
      strategies could be tailored to individual risk profiles.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 6, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative delirium - incidence</measure>
    <time_frame>≤ 2 days postoperatively</time_frame>
    <description>screening through Nu-DESC (Nursing Delirium Screening Scale) ≥ 2 and verification of screening procedure by DSM-V (Diagnostic and Statistical Manual of Mental Disorders 5th Edition) criteria once during each shift</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative delirium - duration</measure>
    <time_frame>≤ 2 days postoperatively or until delirium resolves</time_frame>
    <description>screening through Nu-DESC ≥ 2 and verification of screening procedure by DSM-V criteria DSM-V once during each shift</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative delirium - severity</measure>
    <time_frame>≤ 2 days postoperatively or until delirium resolves</time_frame>
    <description>rated through CAM-S (Confusion Assessment Method - Severity) if patient was identified to be delirious</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative cognitive dysfunction - severity</measure>
    <time_frame>baseline and 3 months postoperatively</time_frame>
    <description>CERAD-Plus (Consortium to Establish a Registry for Alzheimer's Disease - Plus)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pre- and postoperative intelligence</measure>
    <time_frame>baseline and 3 months postoperatively</time_frame>
    <description>MWT-B (Mehrfachwahl-Wortschatz-Intelligenztest - B)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Markers of systemic inflammation</measure>
    <time_frame>≤ 2 days postoperatively</time_frame>
    <description>C-reactive protein, Interleukins, Tumor necrosis factor among others</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Markers of neuroinflammation</measure>
    <time_frame>≤ 2 days postoperatively</time_frame>
    <description>Glial fibrillary acidic protein among others</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Markers of oxidative and metabolic stress</measure>
    <time_frame>≤ 2 days postoperatively</time_frame>
    <description>Malondialdehyd</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>baseline and 3 months postoperatively</time_frame>
    <description>PROMIS-29 (Patient-Reported Outcomes Measurement Information System- Profile 29 incl. proxy-rating)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life - 2</measure>
    <time_frame>baseline and 3 months postoperatively</time_frame>
    <description>SF-36 (Short Form 36)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety and depression</measure>
    <time_frame>baseline and 3 months postoperatively</time_frame>
    <description>HADS (Hospital Anxiety and Depression Scale)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frailty</measure>
    <time_frame>baseline and 3 months postoperatively</time_frame>
    <description>Groningen Frailty Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Structural magnetic resonance imaging</measure>
    <time_frame>baseline and 3 months postoperatively</time_frame>
    <description>White matter lesions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional magnetic resonance imaging</measure>
    <time_frame>baseline and 3 months postoperatively</time_frame>
    <description>Resting state networks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cerebral vasculature</measure>
    <time_frame>baseline</time_frame>
    <description>Ultrasound of extra- and intracranial cerebral arteries</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Genetic polymorphisms</measure>
    <time_frame>baseline</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Cognitive Impairment</condition>
  <condition>Postoperative Delirium</condition>
  <condition>Spine Fusion</condition>
  <arm_group>
    <arm_group_label>Delirium</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>No Delirium</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All patients seen in a neurosurgical oupatient clinic will be screened for eligibility.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age ≥ 60 years

          -  scheduled for elective spine surgery without opening the dura

          -  patient can give informed consent him-/herself

          -  German native speaker

        Exclusion Criteria:

          -  dementia or neurodegenerative disease

          -  psychiatric disease

          -  prescription of CNS-active medication (e.g. antidepressants, antipsychotics,
             sedatives, alpha-1-antagonists)

          -  impossible to participate in follow-up

          -  participation in an interventional trial

          -  electronic or displacable metallic implants

          -  active neoplasm
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Fleischmann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neurology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jonas Müller, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neurosurgery</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Robert Fleischmann, MD</last_name>
    <phone>+49-3834-866870</phone>
    <email>robert.fleischmann@uni-greifswald.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jonas Müller, MD</last_name>
    <email>jonas.mueller@uni-greifswald.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Neurology</name>
      <address>
        <city>Greifswald</city>
        <state>Mecklenburg-Vorpommern</state>
        <zip>17475</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Fleischmann, MD</last_name>
      <phone>+49-3834 86-6870</phone>
      <email>robert.fleischmann@uni-greifswald.de</email>
    </contact>
    <contact_backup>
      <last_name>Jonas Müller, MD</last_name>
      <email>jonas.mueller@uni-greifswald.de</email>
    </contact_backup>
    <investigator>
      <last_name>Robert Fleischmann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jonas Müller, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria Dewey, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stephan Nowak, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2018</study_first_submitted>
  <study_first_submitted_qc>March 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 3, 2018</study_first_posted>
  <last_update_submitted>March 26, 2018</last_update_submitted>
  <last_update_submitted_qc>March 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>delirium</keyword>
  <keyword>postoperative cognitive dysfunction</keyword>
  <keyword>spine surgery</keyword>
  <keyword>elderly</keyword>
  <keyword>neuroinflammation</keyword>
  <keyword>magnetic resonance imaging</keyword>
  <keyword>resting state fmri</keyword>
  <keyword>cerebral vasculature</keyword>
  <keyword>quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cognitive Dysfunction</mesh_term>
    <mesh_term>Delirium</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

